Page last updated: 2024-09-03
vestra and vanoxerine
vestra has been researched along with vanoxerine in 1 studies
*vanoxerine: structure given in first source [MeSH]
*vanoxerine: structure given in first source [MeSH]
Compound Research Comparison
| Studies (vestra) | Trials (vestra) | Recent Studies (post-2010) (vestra) | Studies (vanoxerine) | Trials (vanoxerine) | Recent Studies (post-2010) (vanoxerine) |
|---|---|---|---|---|---|
| 10 | 0 | 9 | 556 | 5 | 93 |
Protein Interaction Comparison
| Protein | Taxonomy | vestra (IC50) | vanoxerine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.5098 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0103 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.5513 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0969 | |
| Small conductance calcium-activated potassium channel protein 2 | Rattus norvegicus (Norway rat) | 0.073 | |
| Small conductance calcium-activated potassium channel protein 3 | Rattus norvegicus (Norway rat) | 0.073 | |
| Small conductance calcium-activated potassium channel protein 1 | Rattus norvegicus (Norway rat) | 0.073 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0424 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.022 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.114 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hartog, PBR; Heitman, LH; IJzerman, AP; Maresca, G; Rossignoli, A; Scarabottolo, L; Sijben, HJ; Stucchi, L; van Oostveen, WM | 1 |
Other Studies
1 other study(ies) available for vestra and vanoxerine
| Article | Year |
|---|---|
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors.
Topics: Biosensing Techniques; Dopamine; Doxycycline; Epinephrine; Fluoxetine; High-Throughput Screening Assays; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Substrate Specificity | 2021 |